SABLICH KIM (Chief Commercial Officer) received a stock award from MYOVANT SCIENCES LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/7/2020ACC: 0001209191-20-023796
Officer· Chief Commercial Officer
Since Dec 2018
+222.27K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
222.27K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+87.81K
Price / share
—
Trade value
—
% of position
149.1%
4/3/2020
58.91K→146.71K
Total
Net shares
+87.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 4/3/2020 | A · Award | +87.81K | — | — | 149.1% | 58.91K | 146.71K |
| Total | +87.81K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Shares
134.46K shares
Shares
+134.46K
Strike price
8.08
Held after
134.46K
Exercisable
—
4/3/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Shares134.46K shares | 4/3/2020 | A · Award | +134.46K | 8.08 | — | 134.46K |